Dantinne, C.

patient response protein protd antigen mage -3 protein mage -3 vaccine vaccination antibody tumor cancer production ifn ␥ cytokine –mage group 4 vaccinations 02b adjuvant adjuvant cytokine production titer melanoma assay postvaccination responder t-cell number study stimulation tumor antigens 300 µ g mage -3baculo protein antibody response j clin oncol evaluable j exp med ifn ␥ production immunother immunol vaccinated evaluable patients effector cells volume peptide lippincott -3baculo elisa mage -3cho protein william protd vaccine responders /april control cancer patients protd –mage protein expression prevaccination residue mage -3 antigen march wilkin mage -3 vaccine dendritic trial metastatic increase result autologou buffer antibody titers immunotherapy pt buffer j immunol purification carcinoma mage -3 proteins eur j immunol int j cancer presence 200 µ l